Advanced search
1 file | 194.92 KB

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

(2010) EUROPEAN JOURNAL OF CANCER. 46(3). p.526-533
Author
Organization
Keywords
III TRIAL, THERAPY, Gemcitabine, CCK2, Gastrin, Pancreas, Cancer, GROWTH

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 194.92 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Meyer, T, ME Caplin, DH Palmer, JW Valle, M Larvin, JS Waters, F Coxon, et al. 2010. “A Phase Ib/IIa Trial to Evaluate the CCK2 Receptor Antagonist Z-360 in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.” European Journal of Cancer 46 (3): 526–533.
APA
Meyer, T, Caplin, M., Palmer, D., Valle, J., Larvin, M., Waters, J., Coxon, F., et al. (2010). A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUROPEAN JOURNAL OF CANCER, 46(3), 526–533.
Vancouver
1.
Meyer T, Caplin M, Palmer D, Valle J, Larvin M, Waters J, et al. A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUROPEAN JOURNAL OF CANCER. 2010;46(3):526–33.
MLA
Meyer, T, ME Caplin, DH Palmer, et al. “A Phase Ib/IIa Trial to Evaluate the CCK2 Receptor Antagonist Z-360 in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.” EUROPEAN JOURNAL OF CANCER 46.3 (2010): 526–533. Print.
@article{1193776,
  author       = {Meyer, T and Caplin, ME and Palmer, DH and Valle, JW and Larvin, M and Waters, JS and Coxon, F and Borbath, I and Peeters, Marc and Nagano, E and Kato, H},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {III TRIAL,THERAPY,Gemcitabine,CCK2,Gastrin,Pancreas,Cancer,GROWTH},
  language     = {eng},
  number       = {3},
  pages        = {526--533},
  title        = {A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer},
  url          = {http://dx.doi.org/10.1016/j.ejca.2009.11.004},
  volume       = {46},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: